Add Company
Join Now

MiroBio Revenue and Competitors

License our Company Data API

Oxford,

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • MiroBio's estimated annual revenue is currently $2.6M per year.(i)
  • MiroBio's estimated revenue per employee is $155,000

Employee Data

  • MiroBio has 17 Employees.(i)
  • MiroBio grew their employee count by -26% last year.

MiroBio's People

NameTitleEmail/Phone
1
Senior Director FinanceReveal Email/Phone
2
Chief Medical OfficerReveal Email/Phone
3
Laboratory ManagerReveal Email/Phone
4
ScientistReveal Email/Phone
5
Scientist II - ImmunologyReveal Email/Phone
6
Financial ControllerReveal Email/Phone
7
Associate ScientistReveal Email/Phone
8
Scientist IIReveal Email/Phone
9
Group LeaderReveal Email/Phone
10
ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.2M27-7%N/AN/A
#10
$10.1M655%N/AN/A
Add Company

What Is MiroBio?

MiroBio is founded by leading immunologists at the University of Oxford who have spent over 15 years focussed on understanding the mechanisms which underlie T-cell signalling. The technology is based on an IP portfolio of novel antibodies with the ability to activate inhibitory co-receptors on the surface of immune cells, with a deep mechanistic understanding, MiroBio is able to optimise these antibodies to create immune-modulatory therapies which have shown remarkable efficacy in preclinical models of disease. MiroBio is now building out the team and the platform looking for strong antibody-development expertise to take the lead compounds to clinical proof-of-concept. MiroBio is a spin-out from the Oxford with an investment of £27M ($34M) from Samsara Biocapital, Oxford Sciences Innovations, Advent Life Sciences and SR One. The company is based in Oxford, retaining close links to the world-class immunology expertise and clinical trial experience within the University.

keywords:N/A

N/A

Total Funding

17

Number of Employees

$2.6M

Revenue (est)

-26%

Employee Growth %

N/A

Valuation

N/A

Accelerator

MiroBio News

2022-03-22 - MiroBio Continues Expansion of Executive Leadership Team ...

MiroBio is a biotechnology company advancing a new class of precision therapies designed to address the immune imbalance that drives autoimmune...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.7M1770%N/A
#2
$1M1731%N/A
#3
$2.6M176%N/A
#4
$2.1M1721%N/A
#5
$2.6M176%N/A